The content on this site is intended for healthcare professionals only
Dr Giampaolo Ugolini talks to ecancer at the 2013 SIOG meeting in Copenhagen about advances in surgery and other treatments that may be especially taxing to elderly patients.
Using information from clinical trials involving younger patients, while keeping in mind that some elderly patients can be healthy but still frail, clinicians must determine the most effective course of treatment without adversely affecting the patient’s quality of life. Other issues are the social situations of elderly patients, such as living in a care home.
SIOG 2024: Updates in medical oncology
ESMO and WCLC: Latest developments in EGFR mutated NSCLC
Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients
ESMO 2024: Highlights and analysis
Immunotherapy resistance pathways investigated to tailor combination NSCLC therapy
Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR Ex20ins NSCLC
Neo-adjuvant therapy for different cancers in the Philippines
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in subset of muscle-invasive bladder cancer patients
